ORIGINAL RESEARCH article

Front. Res. Metr. Anal.

Sec. Scholarly Communication

Volume 10 - 2025 | doi: 10.3389/frma.2025.1594303

Assessing Biomedical Research Capacities in Selected Countries of Latin America: Challenges, Opportunities, and Recommendations

Provisionally accepted
  • 1Science, Technology and International Affairs, Georgetown University, Washington, United States
  • 2Loyola University Maryland, Baltimore, Maryland, United States

The final, formatted version of the article will be published soon.

Persistent gaps in funding, infrastructure, and training underscore the need for targeted strategies to support biomedical research in Latin America. This study contributes to ongoing discussions on regional science policy and international cooperation by addressing knowledge gaps and offering evidence-based recommendations. The findings aim to guide policymakers, funding agencies, and academic institutions in designing interventions that strengthen biomedical research ecosystems. Additionally, the study highlights the importance of international programs in fostering collaboration and advancing regional scientific capacity.A multi-method approach was adopted to collect quantitative and qualitative data on biomedical research capacities in the selected countries. Figure 1 outlines the overall research design and serves as a visual guide to the sequential steps of the study, including the literature review, expert interviews, country selection, survey development and pilot testing; data collection through survey and case study; contextual analysis using socioeconomic, R&D, and publication indicators, and final data analysis and synthesis through both thematic and quantitative methods. [Figure 1. Flow Chart of the Key Components of the Research Design and Methods. This figure illustrates the sequential components of the research design and methods, including literature review, expert input, country selection, data collection, contextualization, and data analysis.]Country Selection and Literature Review. For our study, we selected five countries -Colombia, Peru, Guatemala, Costa Rica, and Panamabased on three primary criteria. First, these countries represent a middle tier of research performance within Latin America. They are positioned below the leading nations such as Brazil, Mexico, Chile, and Argentina, yet they demonstrate significant potential for growth. Second, the selection ensures geographical diversity by including countries from both Central America (Guatemala, Costa Rica, and Panama) and Andean subregion (Colombia and Peru), thereby offering a representative cross-section of scientific and cultural contexts. Third, these countries were chosen because they provided sufficient data on scientific output, socioeconomic indicators, and institutional infrastructure, which enabled a robust and meaningful analysis.

Keywords: Biomedical Research, Latin America, research capacity, Science Policy, R&D investment, global partnerships Font: 10 pt, BOLD

Received: 15 Mar 2025; Accepted: 11 Jun 2025.

Copyright: © 2025 Huete-Perez and Salvatierra. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Jorge A. Huete-Perez, Science, Technology and International Affairs, Georgetown University, Washington, United States

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.